Thus, the more dramatic defects of SHP2 silencing that we observed in the in vivo model compared to the in vitro assays, may reflect contributions of SHP2 to both growth/survival signaling and homing of mastocytoma cells. The gene discussed is PTPN11; the disease is mastocytoma.